We find, analyze and isolate the most valuable cells with ease and speed. Sphere Bio | Cell Selection, Sorted.
Investors 2
| Date | Name | Website |
| 26.05.2025 | Cambridge ... | cambridgea... |
| 06.03.2025 | Parkwalk A... | parkwalkad... |
Mentions in press and media 5
| Date | Title | Description |
| 18.06.2025 | Sphere Bio and Bio-Rad: Pioneering the Future of Life Sciences | In the ever-evolving landscape of life sciences, two companies are making significant strides: Sphere Bio and Bio-Rad Laboratories. Both are expanding their reach and enhancing their product offerings, aiming to meet the growing demands of ... |
| 17.06.2025 | Sphere Bio expands operations in China | Exclusive agreement with specialist biotechnology distributor, Redbert Biotechnology, to strengthen international growth and market penetration Johnathan Fu appointed as China Distribution Manager to lead regional partnerships and enhance c... |
| 21.05.2025 | The Potential of Microfluidics Technology in Cell and Gene Therapy, Upcoming Webinar Hosted by Xtalks | www.spherebio.com In this free webinar, learn why the field is moving from ex vivo to in vivo gene and cell therapies—and what this shift means for scalability and accessibility. Attendees will gain insights into how microfluidics platforms... |
| 09.04.2025 | Sphere Bio expands APAC distribution network to strengthen presence in region | Operational scale-up accelerates global growth strategy to increase regional access and technical support Cambridge, UK, 9th April 2025: Sphere Bio, a leading provider of picodroplet-based microfluidics for functional single-cell analysis a... |
| 31.03.2025 | Sphere Bio launches Cyto-Cellect Human IgG Kappa and Viability Assay Kit for efficient single-cell selection | First multiplexed solution introduced with the next-generation Cyto-Mine Chroma platform for more efficient biotherapeutic development Utilizes advanced picodroplet microfluidics technology to integrate analysis of antibody productivity and... |